Product Code: ETC6189619 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The RNAi therapeutics market in Australia is witnessing growth with increasing interest in gene silencing approaches to treat chronic and genetic diseases. Research into RNAi-based therapies, particularly for liver and neurological conditions, is well-supported by the country`s strong biomedical research capabilities. Challenges such as off-target effects and delivery mechanisms remain areas of active investigation.
RNAi therapeutics in Australia are advancing from research to clinical phases, with emphasis on treating rare and chronic diseases. The market is supported by the Australian Governments Medical Research Future Fund (MRFF) and partnerships with international pharmaceutical companies. Increasing patent activity in RNAi delivery systems also underscores a growing innovation pipeline.
Australias RNAi therapeutics market faces barriers such as difficulties in achieving efficient and targeted gene silencing without triggering immune responses. Additionally, limited local manufacturing infrastructure and dependency on international suppliers for specialized reagents and delivery platforms increase costs and logistics complexity. Intellectual property issues also pose risks in this fast-evolving landscape.
With increasing clinical adoption and regulatory approvals, RNAi therapeutics offer promising investment avenues. Companies focused on silencing disease-causing genes using siRNA or miRNA hold potential, particularly in metabolic, genetic, and cancer-related disorders. Investors can benefit from IP licensing and therapeutic pipeline development.
For RNAi therapeutics, the Australian government has adopted a proactive policy stance, aligning with global trends in gene silencing technologies. The TGA provides guidance on the classification and approval of RNAi-based treatments. Incentives for biopharmaceutical research and innovation, including co-investments in research infrastructure, further drive the growth of the RNAi therapeutics space.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia RNAI Therapeutics Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia RNAI Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Australia RNAI Therapeutics Market - Industry Life Cycle |
3.4 Australia RNAI Therapeutics Market - Porter's Five Forces |
3.5 Australia RNAI Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 Australia RNAI Therapeutics Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Australia RNAI Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia RNAI Therapeutics Market Trends |
6 Australia RNAI Therapeutics Market, By Types |
6.1 Australia RNAI Therapeutics Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Australia RNAI Therapeutics Market Revenues & Volume, By Route of Administration, 2021- 2031F |
6.1.3 Australia RNAI Therapeutics Market Revenues & Volume, By Intradermal Injections, 2021- 2031F |
6.1.4 Australia RNAI Therapeutics Market Revenues & Volume, By Pulmonary Delivery, 2021- 2031F |
6.1.5 Australia RNAI Therapeutics Market Revenues & Volume, By Intravenous Injections, 2021- 2031F |
6.1.6 Australia RNAI Therapeutics Market Revenues & Volume, By Intraperitoneal Injections, 2021- 2031F |
6.1.7 Australia RNAI Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia RNAI Therapeutics Market, By End-User |
6.2.1 Overview and Analysis |
6.2.2 Australia RNAI Therapeutics Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.2.3 Australia RNAI Therapeutics Market Revenues & Volume, By Research and Academic Laboratories, 2021- 2031F |
6.2.4 Australia RNAI Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
7 Australia RNAI Therapeutics Market Import-Export Trade Statistics |
7.1 Australia RNAI Therapeutics Market Export to Major Countries |
7.2 Australia RNAI Therapeutics Market Imports from Major Countries |
8 Australia RNAI Therapeutics Market Key Performance Indicators |
9 Australia RNAI Therapeutics Market - Opportunity Assessment |
9.1 Australia RNAI Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 Australia RNAI Therapeutics Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Australia RNAI Therapeutics Market - Competitive Landscape |
10.1 Australia RNAI Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Australia RNAI Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |